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The Mouse Intestinal Bacterial Collection (miBC)
provides host-speciﬁc insight into cultureddiversity
and functional potential of the gut microbiota
Ilias Lagkouvardos1, Rüdiger Pukall2, Birte Abt2,3, Bärbel U. Foesel2,3, Jan P. Meier-Kolthoff2,
Neeraj Kumar1, Anne Bresciani4, Inés Martínez5, Sarah Just1, Caroline Ziegler1, Sandrine Brugiroux6,
Debora Garzetti6, Mareike Wenning7, Thi P. N. Bui8, Jun Wang9, Floor Hugenholtz8,
Caroline M. Plugge8, Daniel A. Peterson10, Mathias W. Hornef11, John F. Baines9,12, Hauke Smidt8,
Jens Walter5, Karsten Kristiansen13, Henrik B. Nielsen4, Dirk Haller1,14, Jörg Overmann2,3,
Bärbel Stecher3,6 and Thomas Clavel1*
Intestinal bacteria inﬂuence mammalian physiology, but many types of bacteria are still uncharacterized. Moreover,
reference strains of mouse gut bacteria are not easily available, although mouse models are extensively used in medical
research. These are major limitations for the investigation of intestinal microbiomes and their interactions with diet and
host. It is thus important to study in detail the diversity and functions of gut microbiota members, including those
colonizing the mouse intestine. To address these issues, we aimed at establishing the Mouse Intestinal Bacterial Collection
(miBC), a public repository of bacterial strains and associated genomes from the mouse gut, and studied host-speciﬁcity
of colonization and sequence-based relevance of the resource. The collection includes several strains representing novel
species, genera and even one family. Genomic analyses showed that certain species are speciﬁc to the mouse intestine
and that a minimal consortium of 18 strains covered 50–75% of the known functional potential of metagenomes. The
present work will sustain future research on microbiota–host interactions in health and disease, as it will facilitate
targeted colonization and molecular studies. The resource is available at www.dsmz.de/miBC.
Molecular techniques have revolutionized the investigation ofmicrobial ecosystems, but, as a consequence, culture-basedapproaches have been neglected. Interpretation of the
gigantic amount of data obtained by high-throughput sequencing
requires key isolates for precise taxonomic and functional classiﬁ-
cation. Large-scale cultivation of bacteria has primarily been
focused on the human gut1,2. Yet, mouse models allow functional
insights to be gained into host–microbe interactions while testing
the causal role of microbiota in health and disease. However, the
mouse gut microbiota has been poorly characterized, and bacterial
isolates with reference genomes from mice are scarce. Improving
the availability of representative isolates from the mouse gut micro-
biome is essential for future studies using gnotobiotic mice, particu-
larly because the ﬁrst reference gene catalogue of the mouse gut
microbiota shows very limited overlap with human gut microbial
gene diversity3. Furthermore, the host species from which bacteria
originate inﬂuences colonization processes and the effects on host
physiology4–6. Hence, concerted actions to archive and describe bac-
terial isolates in a host-speciﬁc fashion together with appropriate
genomic databases are urgently needed7,8. Pioneering work in the
1960s focused on the isolation of gut bacteria from the mouse intes-
tine9, but classiﬁcation was limited to phenotypic features, and the
majority of strains obtained in these and subsequent studies have
been lost over the years. A very few species remain available (for
example, members of the so-called Altered Schaedler Flora, ASF),
but only under restricted conditions.
In the present work, a comprehensive collection of mouse gut
bacteria was established and made available to the scientiﬁc commu-
nity, including corresponding draft genomes. Important questions
in the ﬁeld were also addressed: ‘Is species diversity host-speciﬁc?’
‘To what extent do cultured bacteria cover the ecosystem diversity
as assessed through molecular methods?’
Results
A comprehensive collection of bacteria from the mouse intestine.
The primary aim of the work was to establish the Mouse Intestinal
Bacterial Collection (miBC) and make it available to the
scientiﬁc community.
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A total of approximately 1,500 pure cultures were isolated from
the intestine of mice, from which strains were selected on the
basis of colony and cell morphology as well as 16S rRNA gene
sequence to cover as much diversity as possible at the species
level. In an effort to unify information scattered throughout the
literature, we also added eight of our own previously published
mouse-derived bacterial species10–17 and four species published
by others18–21.
The diversity of miBC members based on taxonomic lineage is
presented in Fig. 1. The collection contains 100 strains representing
76 different species from 26 families belonging to the phyla
Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria and
Verrucomicrobia (Supplementary Table 1). It is dominated by
Firmicutes (74% of strains), reﬂecting the dominance of this
phylum in the mouse intestine. All isolates were deposited at the
German Collection of Microorganisms and Cell Cultures (DSMZ)
to ensure long-term storage and availability. A speciﬁc list linked
to the metadatabase BacDive22 was created to allow rapid query of
the collection by users (www.dsmz.de/miBC). Hence, miBC is a
unique tool that can serve as a reference for cultivated fractions of
the mouse gut microbiota.
Culturing effort brings novel bacterial diversity and functions to
light. The second purpose of the project was to isolate and describe
new members of the mouse gut microbiota.
Based on 16S rRNA gene sequencing, 15 strains were character-
ized by values with <97% identity to any species described so far,
and draft genomes were generated. Whole proteome-based phylo-
genomic analysis showed that the isolates were distant from known
relatives with available genomic information (Supplementary
Fig. 1). Genome-derived 16S rRNA gene and in silico DNA:DNA
hybridization (DDH) estimates (see Methods) were below species-
level thresholds (98.1% 16S rRNA gene sequence identity or DDH
value of 70%, respectively) (Supplementary Fig. 2, Supplementary
Tables 2 and 3)23. This conﬁrmed that the isolates represented
novel bacterial taxa, including four species, ten genera and one
family. Proposed names are indicated in quotation marks through-
out the manuscript and detailed taxonomic descriptions are pro-
vided below. Microscopic pictures are shown in Supplementary
Fig. 3, and enzymatic proﬁles in Supplementary Table 4. Detailed
characterization revealed that ‘Flintibacter butyricum’ can grow on
the amino acids glutamine and glutamate (but not leucine, aspara-
gine, lysine, arginine and aspartic acid), producing up to 7 mM
butyrate from 20 mM substrate. Moreover, miBC provides the ﬁrst
cultivable member of the ‘Muribaculaceae’ (family S24-7), which
is known to be a dominant bacterial group in the mouse gut6. To
conﬁrm the latter observation and assess the occurrence of all
novel bacteria within miBC, draft genomes were compared to
metagenomic species (MGS)24 from a comprehensive shotgun
sequencing study of the mouse gut metagenome3.
A BLAST search revealed that 5 of the 15 isolates had many
strong matches with the mouse gene catalogue (Supplementary
Fig. 4 and Supplementary Table 5). The other ten isolates had
<200 gene hits (Supplementary Table 5), suggesting that they
either represent subdominant populations in this cohort of mice,
or are not detectable in the mouse gut using the most advanced mol-
ecular methods. The ﬁve novel isolates well represented in the
mouse catalogue showed a high gene coverage (85–99% of genes
at 95% sequence identity), allowing assessment of their prevalence
in the faeces of 184 mice (Supplementary Fig. 4). Two species
were found in the majority of mice: ‘Flintibacter butyricum’ (98%
prevalence) and ‘Enterorhabdus muris’ (76%). Only ‘Flintibacter
butyricum’ was present in all eight mouse strains from all six
animal facilities (ﬁve commercial suppliers), suggesting a wide-
spread colonization of the mouse gut by this amino-acid-degrading
butyrate producer.
In summary, the large-scale culture-based work carried out to
create miBC demonstrates the relevance of isolating and character-
izing bacteria, as it allows the description of novel species that can be
dominant and/or functionally important.
miBC captures the majority of currently cultured bacteria in the
mouse gut. The third aim of the work was to test the relevance of
miBC by assessing the coverage of high-throughput 16S rRNA
gene amplicon inventories. Therefore, we used caecal samples
from 93 mice housed in various facilities in Europe and America
(Supplementary Tables 6 and 7).
Phylogenetic proﬁles of dominant bacterial populations clus-
tered according to animal facilities (Fig. 2a), characterized by
signiﬁcant differences in taxa richness, in the relative abundance
of Bacteroidetes and Firmicutes (Fig. 2b) and by the presence of
indicator species (Supplementary Table 8). This emphasizes the
rationale of working with a multi-centre data set to test the repre-
sentativeness of the collection. As we isolated the ﬁrst cultured
member of family S24-7 and assessed its host-speciﬁcity (next
section), we investigated the distribution of reads classiﬁed as
S24-7 members. They were detected in 86 of 93 mice
(Supplementary Fig. 5), indicating a widespread distribution, in
contrast to the MGS data presented above (Supplementary Fig. 4
and Supplementary Table 5).
Local BLAST analysis of the 772 detected operational taxonomic
units (OTUs) against miBC revealed 46 hits at the species level
(≥97% identity), and 105 at the genus level (≥95%), representing
23.5% of all sequence reads (Fig. 2c). Despite the relatively stringent
quality-check and ﬁltering used for generating the ﬁnal 16S rRNA
gene short reads data set and corresponding OTU table, these per-
centages may underestimate the cultured fractions due to the pres-
ence of spurious OTUs in the high-throughput sequence data.
Looking at the most common and dominant molecular species
(referred to as core OTUs from here on), the 42 OTUs detected in
≥50% of themice at a mean relative abundance of≥0.5% represented
56.8% of the total reads. Nine of these OTUs matched miBC strains
at the genus level (Fig. 2d), accounting for 30% of the core reads.
When searching for additional cultured bacteria (from environments
other than the mouse gut) that represented any OTUs with no match
to miBC, 21 and 48 were identiﬁed at the species and genus levels,
respectively, accounting for only 7.5% extra sequence abundance
(Fig. 2c). Of the 33 core OTUs with no match to miBC, six
matched other cultured bacteria (one at the species and ﬁve at the
genus level; Fig. 2d), accounting for 5.7% of the core reads.
These data indicate that the created bacterial collection already
covers important dominant lineages, although the majority of
mouse gut bacteria remain to be cultured.
Gut bacterial species diversity is host-speciﬁc. Published work
shows that the origin of bacteria inﬂuences colonization processes
and host physiology4,5, but there are only a few reports on the
host speciﬁcity of gut bacterial taxa in human versus mouse3,25.
The fourth aim of the project was to investigate the presence of
miBC species in different ecosystems, especially gut environments,
based on the entire pool of samples in the Sequence Read Archive
(SRA) using IMNGS (www.imngs.org). Raw output data are
provided in Supplementary Table 9.
We ﬁrst looked at the coverage of main SRA sample categories
(environment, n = 17,884; host gut, n = 21,755; other host habitats,
n = 15,414) based on the entire diversity in miBC. The percentage
of data sets where all species in the collection represented >1%
total reads was highest in host gut-derived samples (Fig. 3a), sup-
porting the common sense that bacterial occurrence depends on
major environmental features in different ecosystems. The resolution
of analysis was then reﬁned to mouse and human gut samples.
Almost one-third of the 6,001 mouse samples (28.6%) were
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characterized by a cumulative abundance coverage >50% (that is, the
sum of sequences matching that of miBC species at >97% identity
was more than 50% total reads per sample). This was nearly twice
as much as for human samples (16.6% of 11,705) (Fig. 3b). These
human samples seem to contain relatively high proportions of
short 16S rRNA gene amplicons similar to 16S rRNA genes of
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miBC strains (at 97% identity) and probably do not correspond to
representative ecosystems from the human gut, but rather to speciﬁc
diet- or health-related conditions where a limited number of taxa
dominate. Altogether, these data speak in favour of better coverage
of 16S rRNA gene data sets from the mouse than human intestine
using strains that were isolated from mice to query the database.
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Next, to determine whether certain species may be host-speciﬁc,
we categorized the 76 miBC species according to their prevalence in
human and mouse gut samples (for details see Methods). We
identiﬁed 32 shared species (present in both human and mouse)
and 16 that were characteristic for the mouse intestine (Fig. 3c).
Interestingly, three previously published mouse-derived species
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Figure 3 | Metasearch of 16S rRNA gene short reads for prevalence and abundance studies of miBC members. Species in the collection were used to
query all 16S rRNA gene amplicon data sets stored in the SRA using IMNGS (www.imngs.org), as described in detail in the text. a, Percentage of samples
from main ecological categories for which cumulative abundance of miBC species covered >1 or 10% total reads. b, As in a, including human and mouse gut
samples only. Additional cumulative abundance categories are shown. c, Species-speciﬁc prevalence analysis in human and mouse gut samples. Black
horizontal bars indicate median values. The 76 species in the collection were categorized as described in the Methods. The 18 bacteria selected for creation
of the Minimal Bacteriome (MIBAC-1) are marked with asterisks. These species were selected based on their prevalence and abundance using both the
MGS- and universal 16S rRNA gene amplicon-based surveys described in the text and also according to their phylogenetic diversity. Quotation marks
indicate novel bacterial names proposed in the present study.
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(Enterorhabdus spp., Acetatifactor muris)10,13,17 and ﬁve novel
taxa isolated in the present study (‘Acutalibacter muris’,
‘Enterorhabdus muris’, ‘Turicimonas muris’, ‘Muribaculum intesti-
nale’, ‘Flintibacter butyricum’) were indeed found to be enriched in
the mouse intestine using IMNGS. The remaining 28 species were
either rare or characterized by low prevalence. Among the 16
mouse-enriched species, 9 were also present when considering a
relative abundance of >1% total reads, indicating that these
species are dominant in the mouse gut microbiota.
These ﬁndings suggest that colonization by certain bacterial
species, or at least their occurrence in dominant communities as
detected by sequencing, is host-speciﬁc. A selection of 18 shared
or mouse-enriched species for establishment of a minimal bacter-
iome (MIBAC-1) to model the mouse gut ecosystem are shown
with asterisks in Fig. 3c. This bacterial consortium was further
investigated using genomic approaches.
Genomic novelty and representativeness of cultured mouse gut
bacteria. To evaluate the relevance of miBC and the minimal
consortium of 18 species (MIBAC-1) at the metagenomic level,
draft genomes of the 76 miBC species were compared to
published shotgun metagenomes from the mouse (n = 15) and
human (n = 21) gut (Supplementary Table 10) and to two
metagenomes generated in-house (caecum and faeces of one
speciﬁc-pathogen free (SPF) wild-type mouse). First, a local
database of miBC genomes and the metagenomes in a presence/
absence binary code (1/0) of protein families (PFAM) was created.
Deterministic incremental selection of best-ﬁtted genomes showed
that 12 to 15 species sufﬁced to cover ∼80% of known functional
diversity in metagenomes (Fig. 4a). It also showed that cumulative
information in miBC genomes plateaued at approximately 90%
coverage and that coverage of mouse vs. human metagenomes was
higher (P = 1.66e-10, Kolmogorov–Smirnov test).
Next, we investigated coverage of the mouse metagenomes
(n = 17) by comparing miBC and the minimal bacteriome
MIBAC-1 with consortia from the literature, that is, the ASF26
and the Simpliﬁed Human Intestinal Microbiota (SIHUMI)27.
Coverage analysis included not only the PFAM approach, but
also protein sequence coverage by BLAST analysis (that is, inde-
pendent of functional annotation) for determination of both
homology (≥80% length coverage, E < 10−5) and close sequence
match (≥80% both coverage and sequence similarity). As
expected, both PFAM and sequence coverages were highest for
the entire collection, and coverage decreased with the number
of species included in minimal consortia (18 in MIBAC-1
versus 8 in each of ASF and SIHUMI) (Fig. 4b). To test the
relevance of MIBAC-1 (obtained by data-driven selection), we
analysed 10 selections of 18 strains picked randomly from
miBC (MIBAC-R1 to 10) (Supplementary Table 11). The
designed minimal bacteriome MIBAC-1 was characterized by
higher coverage than the mean of random sets for both sequence
homologues and close matches but not for PFAM (Fig. 4c). This
strengthens the rationale for having selected these strains and
emphasizes the known shallow resolution of analysis when
looking at broad functional categories and the more detailed
speciﬁcity when looking, for instance, at genes3.
Finally, PFAM diversity was investigated by heatmap and den-
drogram analysis. The mouse collection and the metagenomes
formed a cluster that was distant from minimal bacteriomes
(Supplementary Fig. 6). Moreover, although ∼10% of PFAM-
derived information captured by shotgun sequencing was not con-
tained in miBC (Fig. 4a), 437 PFAM detected in the collection and
minimal bacteriomes (representing 2.7% of the total 16,231 PFAM
in all data sets) were absent from metagenomes, 129 of which were
unique to miBC (Fig. 4c). These PFAM (Supplementary Table 12)
are thus not captured by metagenomics, probably because they
originate from taxa that are subdominant or lost during
sample preparation.
Discussion
The extensive use of mouse models is in stark contrast to the lack of
reference bacterial strains from the mouse intestine. In the present
work, we have created a publicly available collection of bacteria
from the mouse gut and provide important insight into host-speciﬁc
bacterial diversity and functions.
Besides delivering an array of mouse gut bacteria to the research
community, miBC contains representative strains of novel taxa,
which represent 15% of the collection (∼1.0% of original isolates
tested). Thus, a substantial number of novel bacteria can still be dis-
covered even via classical bacteriological methods, some of these
bacteria being apparently of particular functional relevance. For
example, mice are colonized by a clade of bacteria from the order
Bacteroidales, originally referred to as MIB (mouse intestinal bac-
teria)28 and nowadays misleadingly classiﬁed as family S24-7 or
Porphyromonadaceae spp. depending on the database. The
present work is the ﬁrst to report the isolation of a cultured
member of this important family in the mouse gut
(‘Muribaculum intestinale’), opening avenues for functional
studies. The collection also includes one strain of each species
Intestinimonas butyriciproducens and ‘Flintibacter butyricum’ able
to produce butyrate not only from sugars but also amino acids. A
human isolate of I. butyriciproducens does so via a metabolic
pathway so far unknown in gut environments29, highlighting the
value of isolating bacteria to unravel functional novelty.
Investigating the mechanisms that underlie the speciﬁcity of bac-
terial colonization in the gut is important to understand the popu-
lation dynamics associated with resilience, resistance to invaders, or
survival of exogenous strains for therapeutic purposes. Occurrence
analysis of the 76 miBC species following a large-scale 16S rRNA
gene amplicon approach revealed that 20% were enriched in mice,
including members of all major phyla. These results add precision
to recent surveys on taxonomic comparison between human and
mouse metagenomes, proposing that lactobacilli and several genera
within the Firmicutes (including Coprobacillus and Turicibacter spp.
within Erysipelotrichaceae, Anaerotruncus within Ruminococcaceae,
Marvinbryantia within Lachnospiraceae, and Pseudoﬂavonifractor
within Clostridiales) are characteristic of mice3,25.
We found that members of the proposed novel family
‘Muribaculaceae’ are speciﬁc to the mouse gut, even though their
presence in humans has been reported by others using quantitative
polymerase chain reaction (qPCR)30. This discrepancy may be
linked to primer speciﬁcity, and additional work is needed to assess
the occurrence of these bacteria in other mammalian species, includ-
ing pigs31. Recent data comparing human and mouse microbiota
reportedmouse-speciﬁc colonization by this family6. Via colonization
of germfreemicewithmicrobial communities frommammals, insects
and environmental samples, the authors of ref. 6 demonstrated that
colonization success (maintained taxa richness and similarity to
input samples) was highest for gut samples, indicating ecosystem-
selective pressure on microbial communities6. Competitive exper-
iments with human versus mouse microbiota revealed transient colo-
nization by human indicator species, but the gut ecosystem was
dominated by mouse species after 14 days (>99% of the community),
especially members of family S24-7 (proposed to be renamed
‘Muribaculaceae’). These observations are in accordance with our
ﬁndings supporting the notion of host-speciﬁc gut colonization.
In contrast to common statements in the literature on the vast
majority of gut bacteria not being cultured, work by Goodman
and colleagues32 reported that approximately 56% of 16S rRNA
gene sequences detected in human faecal samples belong to
readily cultured species. A recent review also reports that the
majority of most dominant species detected by molecular analysis
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Figure 4 | Metagenomic coverage. Coverage was calculated following three complementary approaches: at the level of protein families (PFAM), homologous
proteins (≥80% coverage, E < 10−5 after BLASTp search) and close match (≥80% sequence similarity). a, PFAM-based coverage of faecal metagenomes
from mouse (blue; n = 17) or human (red; n = 21). Data are means ± s.d. Genomes from the mouse collection (x axis) were ranked according to decreasing
contribution to the pool of PFAM in each metagenome. b, Coverages of mouse metagenomes (n = 17) obtained by each of the three approaches already
mentioned for the entire collection (miBC), the minimal consortium described in the present study (MIBAC-1), the Altered Schaedler Flora (ASF) and the
Simpliﬁed Human Intestinal Microbiota (SIHUMI). Boxplots show the median, IQR and whiskers extending to the last data points within +/− 1.5× IQR. Values
for a given analysis type were signiﬁcantly different between all categories (t-test with Benjamini–Hochberg correction). c, Radar plots showing the coverage
of 17 mouse metagenomes (outer ring) by MIBAC-1 and by 10 random sets of 18 strains from miBC (MIBAC-R) at each analysis level (as in b). Random sets
are shown as mean values. Coverages are shown as percentages (grey numbers in the grid) of PFAM, sequence homologues or close matches covered by
the entire collection (miBC values in b). P values were obtained by t-test.
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have cultured representatives33. Analysis of high-throughput
16S rRNA gene amplicons from a mouse cohort covering different
facilities revealed a set of 42 core bacterial OTUs in the mouse gut,
which was covered up to 21% (OTU diversity; 9 of 42) and 30%
(number of reads) by miBC at the genus level. This is the best avail-
able to date, but still lower than the reference values for humans32.
A very recent study reported that the majority of human faecal bac-
teria can actually be cultured1. This highlights the need for further
work to isolate and characterize novel mouse gut bacteria, the
33 core OTUs without match to miBC representing ‘most wanted
taxa’. Moreover, these data support the existence of substantial
differences in gut bacterial diversity and composition between
mouse facilities, which can have dramatic consequences on host
phenotypes34. This emphasizes the need for better characterization
and standardization of complex gut microbial communities based
on the knowledge and bacterial strains gained in the present study
and by others since pioneering work in the 1960s35,36.
The representation of cultured bacteria within miBC was also
assessed at the metagenomic level. The entire collection covered
60–90% of the functional potential in mouse faecal metagenomes.
This high coverage reﬂects the limitation of the analysis to known
functions or homologous protein sequences. Narrowing measure-
ments to the 18-species consortium MIBAC-1, which can be used
as a proxy for native mouse gut ecosystems, revealed coverages of
55–75% (PFAM and sequence homologues) and 20% (close
sequence matches). Minimal consortia of bacteria already exist in
the literature, but strains were selected based on educated guesses
or for speciﬁc purposes and either originated from the human intes-
tinal tract or are not easily available26,27,37. In contrast, the minimal
bacteriome presented here contains strains that originate from the
mouse intestine, is publicly available, was selected on the basis of
comprehensive sequence-based approaches, and was overall charac-
terized by a higher coverage of mouse faecal metagenomes. Hence, it
represents important progress towards the standardization of mouse
models, as emphasized by others35,38. However, additional work is
required for establishment of the consortium in vivo.
Demonstrating stable colonization, which can be inﬂuenced by
many ecological factors, is indeed very important and challenging,
but is beyond the scope of the present study.
In conclusion, the signiﬁcance of our work to the ﬁeld and the
broader community is manifold: (1) it provides the basis for genetic
studies that will eventually improve the resolution ofmeta-omics ana-
lyses of the mouse gut microbiome; (2) unrestricted access to miBC
strains is a major advance for the research community, especially
for functional studies on cause-and-effect relationships and for stan-
dardizing experiments among laboratories; and (3) the collection
includes mouse-enriched taxa and strains with speciﬁc metabolic
functions such as butyrate production, allowing ecological studies
and assessment of the impact of speciﬁc strains on host physiology
and disease onset. We acknowledge the fact that miBC is not an
exhaustive collection; important bacterial taxa are still missing (for
example, segmented ﬁlamentous bacteria or species of the phyla
TM7 and Deferribacteres) and other microorganisms such as fungi
and archaea, as well as viruses, are also important to investigate39,40.
Moreover, key metabolic functions such as the conversion of bile
acids require more detailed investigation. Also, strain diversity is
most probably very important in gut environments41, but the collec-
tion offers resolution at the strain level for only a few species
(especially lactobacilli), as the aim was to cover as much diversity as
possible at the species level. Nevertheless, recent metagenomic
work41 also emphasizes the necessity to obtain reference genomes
and thus the beneﬁt of isolating and describing bacteria, as done
extensively in the present work. Hence, knowledge of the mouse
gut bacterial diversity made available via miBC can be viewed as a
foundation that now requires effort by the entire community of gut
microbiome researchers for further development.
Methods
Mouse samples for cultivation. The use of mice was approved by the local
authorities in charge (animal welfare authorization 32–568, Freising District
Ofﬁce; Regierungspräsidium Freiburg T05-28). Laboratory mice were housed
in conventional or speciﬁc pathogen-free facilities at the WZW School of Life
Sciences (TU München), the Institute for Medical Microbiology and Hygiene
(Universitätsklinikum Freiburg) or the Rodent Center (ETH Zurich). Samples from
mice captured in the wild were obtained as described previously42. Starting materials
for bacteria isolation included fresh faeces collected from living mice, mucosal
samples, as well as small intestinal, caecal or colonic content collected frommice that
had been euthanized by CO2 inhalation or neck dislocation. The origins of bacteria
(those eventually included in the collection) in terms of mouse genotype and gut
location are provided in Supplementary Table 1. The working area and dissection set
were cleaned and mice were copiously sprayed with 80% (vol/vol) ethanol before
dissection in order to avoid contamination. In some instances, mice were dissected
inside the anaerobic workstation to prevent any contact of gut samples with oxygen.
Culture media. All quantities are per litre of medium.
A II: Brain–heart–infusion (BHI), 18.5 g; yeast extract, 5 g; trypticase soy broth,
15 g; K2HPO4, 2.5 g; hemin, 10 µg; glucose, 0.5 g; palladium chloride, 0.33 g; agar,
15 g. After autoclaving, add Na2CO3, 42 mg; cysteine, 50 mg; menadione, 5 µg; fetal
calf serum (complement-inactivated), 3% (vol/vol). Adapted from Aranki
and Freter43.
BAC: WCA (Oxoid; CM0643; see manufacturer’s instructions); Agar, 1.5 g;
PdCl, 1 mg, dissolve ﬁrst in HCl; phenosafranine, 2.5 mg; set pH to 7.0. After
autoclaving (121 °C, 15 min), add kanamycin, 50 µg ml–1; cysteine (0.05% wt/vol),
dithiothreitol (DTT) (0.02%), sheep blood (5% vol/vol), 1 vial of G-N Anaerobe
Supplement (Oxoid SR0108) per 475 ml medium.
BARN: 1× Sigma salt (M6030); yeast extract, 0.5 g; maltose, 1 g; agar, 15 g;
PdCl2 2 mg; phenosafranin; set pH to 7.6. After autoclaving (121 °C, 15 min), add
penicillin (25 µg ml–1), vancomycin (20 µg ml–1), kanamycin (50 µg ml–1), cysteine
(0.05% wt/vol), trace element and vitamin solutions (see DSMZ medium 104 PYG).
BHI: DSMZ medium 215c (supplemented or not with 15 g agar).
BIL: 1× Sigma salt (M6030); peptone, 2 g; yeast extract, 200 mg; agar, 1.5 g; PdCl
(1 mg; dissolve ﬁrst in HCl); phenosafranine (2.5 mg). After autoclaving (121 °C,
15 min), add Oxgall (1.5% vol/vol; Fluka ref. B3883), taurine (200 µM), cysteine
(0.05% wt/vol), TUDCA (100 µg l–1; Santa Cruz Biotechnol, ref. sc296449).
BLS: Blood agar with 10 mg l–1 colistin sulfate and 5 mg l–1 oxolinic acid.
COR: 1× Sigma salt (M6030); Tween 80 (1 ml); pig mucin type III (Sigma)
(250 mg; Sigma M1778); agar (1.5% wt/vol); PdCl (1 mg; dissolve ﬁrst in HCl);
phenosafranine (2.5 mg). After autoclaving (121 °C, 15 min), add arginine, glycine,
histidine and lysine (each 2.5 g), bile salts (0.5% wt/vol; Fluka ref. 48305), cysteine
(0.05%), DTT (0.02%), sheep blood (5% vol/vol). For COR2 agar, add ampicillin and
neomycin (50 µg ml–1 each) after autoclaving (121 °C, 15 min).
ECSA: 17.0 g pancreatic digested casein; 3.0 g peptic digested casein; 5.0 g yeast
extract; 10.0 g ox gall; 5.0 g sodium chloride; 1.0 g aesculin; 0.5 g ammonium
iron (III) citrate; 0.25 g sozium azide; 1.0 g sodium citrate; 13.5 g agar.
mOs-SRB: 11.28 g M9 minimal salt medium (Sigma 6030); 20.0 g agar; 2.0 g
Na2SO4 anhydr.; 75 mg yeast extract; 75 mg Li-lactate. After autoclaving, add
cysteine (0.05% wt/vol), DTT (0.02%).
MT10: 1× Sigma salt (M6030); pig mucin type III (Sigma) (250 mg; Sigma
M1778); PdCl2 2 mg; thioglycolic acid, 0.1 g; phenosafranin; 50 ml rumen ﬂuid; agar,
15 g; set pH to 7. After autoclaving (121 °C, 15 min), add rifampicin (20 µg ml–1),
cysteine (0.05% wt/vol), 2-mercaptoethanol (50 µM), trace element and vitamin
solutions (see DSMZ medium 104 PYG).
Postgate (after Postgate, Appl Microbiol 1963, 11:265): KH2PO4, 0.5 g; NH4Cl,
1 g; Na2SO4, 2 g; CaCl2.6H2O, 0.1 g; MgSO4.7H2O, 1 g; Na-lactate, 3.5 g; yeast
extract, 1 g; thioglycolic acid, 0.1 g; FeSO4.7H2O, 0.5 g; agar, 15 g; NaHCO3, 2 g;
PdCl2 2 mg; phenosafranin; set pH to 7.6. After autoclaving (121 °C, 15 min),
add penicillin (25 µg ml–1), trace element and vitamin solutions (see DSMZmedium
104 PYG).
PYF: Peptone-yeast extract broth with 4% (vol/vol) Fildes’ digest (peptic
digestive of horse blood)19.
PYG: DSMZ medium 104; 15 g agar.
TA-BHI: Tannic acid-treated BHI agar, prepared as described in ref. 44.
TGB: Thioglycollate medium brewer modiﬁed (Becton, Dickinson and
Company, cat. no. 5211716); 15 g agar; 0.5 ml l–1 thioglycolic acid (AppliChem;
cat. no. A3533).
WCA: Wilkins–Chalgren Anaerobe (Oxoid, ref. CM0643).
WHC: WCA (oxoid) + 25 µg ml–1 penicillin (sodium salt).
WSB: WCA (Oxoid), 33 g; glucose, 4 g; hemin, 10 µg; L-cystine, 0.4 g; agar, 15 g.
After autoclaving, add deﬁbrinated sheep blood (Oxoid) 5% (vol/vol).
Bacterial strains isolation. Gut samples were re-suspended (1:10 wt/vol) in reduced
buffered solutions or broth media (see composition above in the section ‘Culture
media’). Mucosal samples were prepared as described previously10. Tenfold dilution
series of gut suspensions were plated on agar media (see composition above) and
bacteria were allowed to grow for 2–30 days under aerobic conditions, or in an
anaerobic chamber containing a mixture of hydrogen, nitrogen and carbon dioxide
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(5:10:85) or hydrogen and nitrogen only (10:90). Single colonies were streaked at least
three times onto fresh agar plates before transfer into broth media. Bacterial smears
formed after growth of low dilutions were also re-streaked to obtain single colonies of
low-abundant bacteria. Culture purity was ensured byobserving colonymorphology as
well as cell morphology by lightmicroscopy after Gram-staining. For identiﬁcation and
phylogenetic analysis of isolates, DNAwas extracted from pure cultures and 16S rRNA
genes were ampliﬁed and sequenced as described previously15. Electropherogram
quality was checked and contigs were built using Bioedit45. Sequences were identiﬁed
using EzTaxon46. The value of 97% 16S rRNA gene sequence identity, which is awidely
used and generally accepted though rather conservative threshold, was chosen to
delineate novel taxa in a consistent manner across bacterial phyla23. Further
characterization of the strains is detailed in the next section. Routine media used for
subculturing strains included reduced Wilkins Chalgren anaerobic (WCA) broth
(Oxoid) supplemented with cysteine (0.05% wt/vol) and DTT (0.02%) as reducing
agents. Cryo-stocks were prepared from freshly grown cultures by mixing bacterial
suspensions 1:1 with ﬁlter-sterilized glycerol in culture medium (40% vol/vol) before
freezing at −80 °C. Live and cryo-cultures of isolates were shipped to the German
Collection of Microorganisms and Cell Cultures (DSMZ), where stocks for long-term
storage were prepared and detailed taxonomic characterization was carried out. Strain
information (including culture conditions) is available online at www.dsmz.de/miBC.
Strain characterization. Analyses included cell morphology by microscopy,
enzymatic testing, cellular fatty acids, diaminopimelic acid, automated ribotyping
and mass spectrometry analysis using a MALDI-biotyper (Bruker). Matrix-assisted
laser desorption/ionization-time of ﬂight (MALDI-TOF) sample preparation was
performed according to protocol 3 as described by Schumann and Maier47.
Ribotyping was carried out using the automated Riboprinter microbial
characterization system (Dupont, Qualicon). Sample preparation and analysis were
performed according to the manufacturer’s instructions and EcoRI restriction
enzyme was used to generate the DNA fragments. Protocol 1, published by
Schumann48 was applied to screen Gram-positive bacterial cells for the presence of
diaminopimelic acid. Two loops of wet biomass were added to 200 µl of 4 N HCl in
2 ml glass ampoules, which were heat-sealed and kept for 16 h at 100 °C. After
cooling, hydrolysates were pressed through a charcoal bed using a pipette bulb and
dried in a gentle air stream at 35 °C until all traces of acid were eliminated.
Hydrolysates were dissolved in 100 µl distilled water and a volume of 2 µl was
spotted on the baseline of cellulose thin-layer chromatography (TLC) plates
(Merck, P/N 1.05577) using a glass capillary. For separation of the diamino acid, a
solvent system was used according to ref. 49 (32 ml methanol, 4 ml pyridine, 7 ml
distilled water and 1 ml 12 N HCl; all from Sigma-Aldrich). TLC plates were sprayed
with ninhydrin reagent after development. Spots became visible after heating
(100 °C, 5 min). Cellular fatty acids were determined from cells grown on blood
agar plates or collected from pre-reduced liquid media. Fatty acids were analysed
as methyl ester derivatives obtained from 10 mg dry cell material by saponication,
methylation and extraction using the modiﬁcations by Kuykendall et al.50 of the
method by Miller51. The fatty acid methyl esters were separated and identiﬁed using
the Microbial Identiﬁcation System (MIDI) Sherlock version 6.1 (TSBA40 database).
Enzymatic testing was done according to the manufacturer’s instructions
(Biomérieux). Cell morphology was examined using phase-contrast microscopy
(Zeiss Axioscope A.1, ×100 Plan-Neoﬂuar oil-immersion objective, Ph3; Zeiss
Axiocam MRc; Axiovision software). Slides were coated with a layer of highly
puriﬁed agar (2%).
High-throughput 16S ribosomal RNA gene analysis. For analysis of mouse gut
microbiota based on 16S rRNA gene amplicon sequencing with ensuing
determination of core mouse gut bacteria, caecal samples were obtained from a total
of 93 mice housed in eight different facilities in Europe and America
(Supplementary Table 6). The aim was to obtain a data set that was not speciﬁc to
one facility, and thus was as representative as possible of bacterial communities in
the distal mouse intestine.
Mice were killed and caeca were immediately removed, placed in cryo-vials and
snap-frozen in liquid nitrogen. Samples were stored at −80 °C until shipped on dry
ice to the University of Nebraska at Lincoln and stored again at −80 °C until further
processed. Once all samples were collected, they were thawed under anaerobic
conditions and diluted 1:10 in sterile phosphate-buffered saline with 10% glycerol.
Aliquots (200 µl) of each sample were used for DNA extraction following procedures
described elsewhere52. 16S rRNA gene tag sequencing (MiSeq, Illumina) of V5–V6
regions was performed at the University of Minnesota Genomics Center using
primers 784F (5′-RGGATTAGATACCC′) and 1064R (5′-
CGACRRCCATGCANCACCT)53.
Raw sequence reads were processed using IMNGS (www.imngs.org) with a
pipeline developed in-house based on UPARSE54. Details about the analysis have
already been described elsewhere55. OTUs clustered at 97% sequence identity and
occurring at a relative abundance of ≥0.1% total reads in at least one sample were
analysed further. The analysis delivered 14,906,121 quality- and chimera-checked
reads (160,281 ± 60,686 per sample) that clustered in 772 OTUs (344 ± 45 OTUs per
sample) (Supplementary Table 7 and Supplementary Sequence File).
For phylogenetic analysis, the evolutionary history was inferred by using the
maximum likelihood method based on the ‘General Time Reversible model’ and
using 200 bootstrap replications in MEGA6 (ref. 56). The tree with the highest
log-likelihood (representing the most probable tree topology) was selected. The
percentage of trees in which the associated taxa clustered together was shown next to
the branches (the tree was condensed to values ≥50%). All positions with <70% site
coverage were eliminated. That is, fewer than 30% alignment gaps, missing data and
ambiguous bases were allowed at any position. There were a total of 261 positions in
the ﬁnal data set.
Integrated 16S rRNA gene amplicon studies. To evaluate the prevalence and
abundance of miBC members in gut microbiota, other host-derived ecosystems and
environmental samples, we used an integrated metagenomic platform developed
in-house and used in previous work (www.imngs.org)16,57. All 16S rRNA gene
amplicon studies available in the SRA58 were extracted and organized in sample-
speciﬁc databases. The IMNGS build 1510 used in the present study contained a
total of 55,073 samples, including 6,001 and 11,705 from the mouse and human gut,
respectively. The corresponding databases were searched using UBLAST59 based on
nearly full-length 16S rRNA gene sequences of the 76 miBC species as queries to
ensure good coverage across all studies, independent of 16S rRNA gene regions.
Results were ﬁltered on length (>200 nt), coverage (>70% read length) and similarity
(>97 or 99%).
To determine whether certain species were host-speciﬁc, we looked at the
number of SRA-derived samples positive for each species included in the collection,
that is, those mouse or human samples in which sequences matched the
corresponding 16S rRNA gene sequence at the level of 97% similarity. Of note, each
OTU with a miBC match collected via IMNGS was subsequently assigned to one
single closest sequence in the miBC reference set in order to avoid redundancy issues
in the case of genera with closely related species (for example, for lactobacilli,
enterococci, staphylococci). Prevalence had to be at least 5% in mouse gut samples so
that species were considered for discriminative analysis between human and mice.
The parameters used to categorize species were as follows: (1) rare: the species had a
prevalence of <1% of mouse samples; (2) low prevalence: <5% mouse samples;
(3) shared: the percentage of positive samples from human gut was at least as high as
those from mice; (4) shared and dominant: deﬁnition in category 3 held true also
when considering only SRA-derived OTUs occurring at a relative sequence
abundance of >1% total reads (dominant OTUs); (5) mouse-enriched: the
percentage of positive gut samples from mice was at least twice that from human
subjects; (6) mouse-enriched and dominant: the given species was also enriched
in mice when considering only dominant SRA-derived OTUs (as deﬁned in
category (4)).
For the interpretation of results, it is important to remember that the analysis
described above is based on short 16S rRNA gene amplicons, which can affect
similarity-based results when compared to full-length gene analysis. Moreover,
although it is reasonable to assume that the large-scale analysis (including thousands
of samples from many different studies) guarantees a certain degree of
representativeness, sample descriptions in SRA can be imprecise and the analysis
certainly includes outlier samples for a given ecosystem (for example, from hosts
with peculiar pathophysiological conditions).
Genome sequencing and processing. A total of 53 draft genomes were obtained in
the present study (EBI project accession no. PRJEB10572). The 53 strains were
selected following three criteria: (1) novelty; (2) relevance according to the IMNGS
and MGS analysis (mouse-enriched, prevalent or dominant); and (3) need to ﬁll
diversity gaps (species with no genome yet available). The miBC collection also
includes 12 strains, for which novel genomes have already been deposited and will be
published in a separate study (SRA accessions are provided in Supplementary
Table 1). Genomes from 11 additional species in the collection were retrieved from
NCBI (Supplementary Table 1). The corresponding raw sequence ﬁles were
processed as for the genome sequences generated in-house.
Genomic DNA was obtained from pure cultures by precipitation after
mechanical lysis following a protocol published previously60. DNA libraries were
prepared using the TruSeq DNA PCR-Free Sample Preparation Kit (Illumina). The
protocol was optimized (DNA shearing and fragment size selection) to improve
assembly quality61. Libraries were sequenced using the Illumina MiSeq system
according to the manufacturer’s instructions.
Reads were assembled using Spades v3.6.1 with activated BayesHammer tool for
error correction and MismatchCorrector module for post-assembly mismatch and
indel corrections62. Assemblies were evaluated using Quast v3.1 (ref. 63). Prediction
and annotation of open reading frames (ORFs) on contigs >1,000 nt were performed
with prokka v1.11 (ref. 64). Genome sequences were submitted to the European
Nucleotide Archive and are available under the accession numbers provided in
Supplementary Table 1.
Genome-based analyses. 16S rRNA gene sequences were extracted from both the
mouse isolate genomes and reference genomes using RNAmmer (ref. 65). All
pairwise similarities among these sequences were calculated from exact pairwise
sequence alignments using recommended settings23.
For digital DNA:DNA hybridization (dDDH), the Genome-to-GenomeDistance
Calculator 2.0 (GGDC), a web service freely available at http://ggdc.dsmz.de,
provided a genome sequence-based delineation of (sub-)species by reporting dDDH
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estimates as well as their conﬁdence intervals66. This approach was shown to have
several advantages over alternative species delineation approaches66,67, without
mimicking the pitfalls of conventional DDH.
Awhole-genome phylogeny (based on the proteome data) was inferred using the
latest version of the Genome-BLAST Distance Phylogeny (GBDP) method66,68.
Here, pairwise proteome comparisons (including pseudo-bootstrap replicates) were
performed under the greedy-with-trimming algorithm and further recommended
settings69. The ﬁnal tree was inferred using FastME v2.07 with TBR post-
processing70. GBDP settings were trimming algorithm, formula d5 and an e-value
threshold of 10e-8. The tree was rooted at the mid-point71 and numbers above
branches are greedy-with-trimming pseudo-bootstrap support values from 100
replicates. Only support above 60% is shown.
The difference in genomic G+C content was used to delineate species. When
computed from genome sequences, the G+C content differences vary no more than
1% within species67.
Similarity search against the mouse gene catalogue. The mouse gene catalogue3
was searched against each of the 15 genome databases separately, using BLASTn
(ref. 72). The gene matched criteria were percent identity ≥95% over 100 bp or more
and e-value ≤10×10-5 (very similar results were obtained using 80% coverage
threshold with ≥95% identity. The number of gene matches assigned to
metagenomic species (MGS), as deﬁned previously3,24, was counted (see
Supplementary Table 5 for details). The occurrences of the ﬁve MGS through the
mouse cohort sampled in ref. 3, with 85% of the genes matching the novel isolates,
were used to generate Supplementary Fig. 1b.
Metagenome analysis. Metagenomic DNA was extracted from mouse intestinal
contents as described above for pure cultures60. Libraries of 300 bp insert sizes were
prepared from 500 ng fragmented DNA (Covaris S220 AFA System; duty factor
10%, peak incident power 175 W, 200 cycles per burst, 40 s) for each sample using
the NEBNext Ultra DNA Library Prep Kit for Illumina (E7370S, New England
Biolabs) according to the manufacturer’s instructions. Samples were barcoded and
sequenced on a TruSeq Rapid PE ﬂowcell (PE-402-4001; Illumina) using an
Illumina HiSeq 2500 sequencer with TruSeq Rapid SBS chemistry (FC-402-4001)
and the 2 × 100 bp paired-end read module. Real-time analysis (RTA) software
(1.17.20) was used for image analysis and base calling. Sequence ﬁles (.fastq) were
generated with the CASAVA BCL2FASTQ Conversion Software (1.8.3). Paired-end
sequencing reads were assembled into metagenomics contigs using Megahit73.
Contigs with a length of >500 nt were classiﬁed with Kraken74 and those classiﬁed as
bacteria were kept for further analysis.
Three complementary approaches were followed to determine metagenomic
coverage by cultivated bacteria. First, a local database was created of all miBC
genomes and the metagenomes in a presence/absence binary code (1/0) of protein
families (PFAM). Deterministic incremental selection of best ﬁtted genomes was
performed to assess coverage of the metagenomes by all miBC species (n = 76), or
by species included in the minimal bacteriome MIBAC-1 (n = 18; this study),
SIHUMI (n = 8)27 and ASF (n = 8)26. Second, ORFs in metagenomic contigs were
selected and initial annotation was carried out with prokka64. The predicted
metaproteome of miBC and the three minimal bacteriomes were used for creation of
protein BLAST databases. Sequence coverage of metagenomes was calculated
based on a BLASTp search. ORFs that signiﬁcantly (expected value E < 10−5)
aligned with a database entry protein at minimum length coverage ≥80% were
used for the calculation of functional coverage (that is, at the level of homologous
proteins). Third, from the ORFs retained in step (2), only those with ≥80%
sequence similarity were used for calculation of close match sequence coverage.
Of note, all newly generated or database-derived metagenomes used in the
present analysis were completely independent of the samples used for strain isolation.
Description of novel bacteria. The descriptions are based on genome sequence
analysis, enzymatic testing and chemotaxonomy (cellular fatty acids and detection of
meso-diaminopimelic acid). Genome-based analyses included whole proteome-
based phylogenomic GBDP analysis, dDDH, 16S rRNA gene sequence analysis and
differences in G+C content of DNA. First, the relative subtree height (RSH) of any
given putative novel bacteria within the phylogenomic tree relative to the RSH of
related species allowed reliable conclusions on the taxonomic properties of novel
strains. Second, a dDDH value of <70% indicated afﬁliation of an isolate to a novel
species. Third, a 16S rRNA gene sequence identity of ≤94.5% was considered strong
evidence for different genera and ≤86.5% for distinct families75. Fourth, because
within-species differences in the genome-based G+C content of DNA are almost
exclusively <1%, larger differences strongly supported the status of distinct species.
Finally, percentage of conserved proteins (POCP) analysis was done using the IMG
software tool Genus deﬁnition76,77, considering genus delineation at a POCP
value of <50%.
Novel bacterial taxa included (1) four species: ‘Bacteroides caecimuris’ strain
I48T (=DSM 26085T = KCTC 15547T), ‘Blautia caecimuris’ strain SJ18T (=DSM
29492T = KCTC 15541T), ‘Enterorhabdus muris’ strain WAC-131-CoC-2T (=DSM
29508T = KCTC 15543T) and ‘Pasteurella caecimuris’ strain AA-424-CC-1T (=DSM
28627T = KCTC 52216T); (2) ten genera: ‘Longicatena caecimuris’ strain PG-426-
CC-2T (=DSM 29481T = KCTC 15535T), ‘Longicella muris’ strain MT10-315-CC-
1.2-2T (=DSM 29487T = KCTC 15536T), ‘Extibacter muris’ strain JM-40T (=DSM
28560T = KCTC 15546T), ‘Muricomes intestini’ strain 2-PG-424-CC-1T (=DSM
29489T = KCTC 15545T), ‘Turicimonas muris’ strain YL45T (=DSM 26109T =
KCTC 15542T), ‘Frisingicoccus caecimuris’ strain PG-426-CC-1T (=DSM 28559T
= KCTC 15538T), ‘Flintibacter butyricum’ strain BLS21T (=DSM 27579T = KCTC
15544T), ‘Cuneatibacter caecimuris’ strain BARN-424-CC-10T (=DSM 29486T =
KCTC 15539T), ‘Acutalibacter muris’ strain KB18T (=DSM 26090T = KCTC
15540T), ‘Irregularibacter muris’ 2PG-426-CC-4.2T (=DSM 28593T = KCTC
15548T); and (3) one member of a novel family: ‘Muribaculum intestinale’ strain
YL27T (=DSM 28989T = KCTC 15537T) within the ‘Muribaculaceae’.
Description of Acutalibacter gen. nov. Acutalibacter (Ac.tu.al.i.bac’ter. L. adj.
acutalis tapered, pointed; N.L. n. bacter rod; N.L. neut. n. Actualibacter a rod-shaped
bacterium with tapered ends, pertaining to the cell morphology of the type strain of
the type species).
The closest phylogenomic neighbour is Clostridium sporosphaeroides. Both
genomes cluster distantly from Clostridium leptum. They do not represent members
within the Clostridium sensu stricto cluster. The dDDH is 23% and POCP is 41%,
indicating the status of a separate genus, for which the name Acutalibacter is
proposed. The dDDH value between the genome of strain KB18T and Ruminococcus
bromii L2-63 is 25.6%. The G+C content of genomic DNA of the type strain is
54.6 mol%. The type species is Acutalibacter muris.
Description of Acutalibacter muris sp. nov. Acutalibacter muris (mu’ris L. gen.
n.muris of a mouse). Its cells are long rods with tapered ends. It is strictly anaerobic.
It is positive for α-galactosidase, β-galactosidase, β-galactosidase-6-phosphate,
β-glucosidase, α-arabinosidase, β-glucuronidase and α-fucosidase (Rapid ID32A)
and esculin hydrolysis (Api 20A).
D-xylopyranose can be formed from xylose, which is converted to D-xylulose by
xylose isomerase activity. D-xylulose is subsequently phosphorylated to D-xylose
5-phosphate (E.C. 2.7.1.17, xylokinase, 01104), an intermediate of the pentose
phosphate pathway. Hemicellulose consists of xylan, which is linked with sugar side
chains (arabinose, galactose). Arabinoxylan can be converted to xylan by an
arabinofructofuranose (E.C. 3.2.1.55, 00023). Xylan can be hydrolysed by E.C.
3.2.1.37, xylosidase (00237, 02775) or E.C. 3.2.1.54, dextrinase (03478). Several
esterases are detectable within the genome.
The main cellular fatty acids comprise C16:0 (22.1%), C16:0 DMA (21.7%), iso-C15:0
(16.8%), anteiso-C15:0 (9.8%) and C18:1 ω9c (12.2%). The diagnostic amino acid of the
peptidoglycan type is meso-diaminopimelic acid. The type strain is KB18T (=DSM
26090T = KCTC 15540T).
Description of Bacteroides caecimuris sp. nov. Bacteroides caecimuris (cae.ci.
mu’ris. L. n. caecum caecum; L. n. muris of a mouse; N. L. gen. n. caecimuris from
the caecum of a mouse). The closest phylogenomic neighbour is Bacteroides
acidifaciens and the dDDH value between both genomes is 40.2%.
It is strictly anaerobic, Gram-negative, and in the form of short rods. It is positive
for α- and β-galactosidase, β-galactosidase 6-phosphate, α- and β-glucosidase,
α-arabinosidase, β-glucuronidase, α-fucosidase, alkaline phosphatase, leucine
arylamidase and alanine arylamidase (Rapid ID 32A). It is positive for esculin
hydrolysis and for acidiﬁcation from D-glucose, D-lactose, saccharose, D-maltose,
salicin, D-xylose, L-arabinose, D-cellobiose, D-mannose, D-rafﬁnose, L-rhamnose and
D-trehalose (Api 20A).
The strain is able to degrade pectin consisting of polygalacturonan and
rhamnogalacturonan. The end products are D-galactopyranuronate and 4-deoxy-L-
threo-hex-4-enopyranuronate. Pectin can be depolymerized by esterase activity.
Enzymes include E.C. 3.1.1.11, Prokka_03269; E.C. 3.2.1.82, galacturonisidase,
Prokka_03292; E.C. 4.2.2.23, rhamnogalacturonan endolyase, Prokka_03307;
E.C. 4.2.2.24, rhamnogalacturonan exolyase, Prokka_03311; E.C. 3.2.1.172,
rhamnogalacturonyl hydrolase, Prokka_03310.
β-L-rhamnopyranose can be converted to L-lactaldehyde and dihydroxyacetone
phosphate, which can enter glycolysis (E.C. 5.3.1.14, L-rhamnose isomerase,
Prokka_01322; E.C. 2.7.1.5, L-rhamnulokinase, Prokka_01323; E.C. 4.1.2.19,
phosphate-aldolase, Prokka_01320). Xylose can be converted to D-xylulose
5-phosphate, which can enter the pentose phosphate pathway (E.C. 5.3.1.5, D-xylose
epimerase, Prokka_03917; E.C. 2.7.1.17, kinase, Prokka_03916). The pentose
phosphate pathway includes E.C. 5.3.1.6, Prokka_01016; E.C. 5.1.3.1, Prokka_00323;
E.C. 2.2.1.1, Prokka_01617; E.C. 2.2.1.2, Prokka_03873; E.C. 2.2.1.1, Prokka_01617).
The end product is D-glyceraldehyde 3-phosphate.
Trehalose can be converted to α-D-glucose and β-D-glucopyranose. The latter
can be used to form β-D-glucose 6-phosphate, which can enter glycolysis (E.C.
3.2.1.28, Prokka_00582; E.C. 5.1.3.3, Prokka_01268; E.C. 2.7.1.2, Prokka_01994).
Melibiose can be converted to α-D-galactose and α-D-glucose. Starch can be
degraded to form β-D-glucose 6-phosphate and β-D-glucopyranose, which may enter
glycolysis (E.C. 3.2.1, α-amylase, Prokka_03907; E.C. 2.4.1.1, Prokka_00503; E.C.
5.4.2.2, Prokka_01849; E.C. 2.4.1.25, Prokka_00656; E.C. 5.1.3.3, Prokka_01994).
L-glutamine can be converted to L-glutamate (E.C. 3.5.1.2, Prokka_01943),
which can be dehydrogenized to 2-oxoglutatarate (E.C. 1.4.1.2, Prokka_02968) or
converted to ammonium and fumarate (E.C. 2.6.1.1, Prokka_01814; E.C. 4.3.1.1,
Prokka_02293).
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Major cellular fatty acids are anteiso-C15:0 (33.7%), iso-C17:0 3-OH (15.9%),
iso-C15:0 (13.3%), C16:0 3-OH (7.5%) and C16:0 (4.8%). The G+C content of genomic
DNA is 42.6%. The type strain is I48T (=DSM 26085T = KCTC 15547T).
Description of Blautia caecimuris sp. nov. Blautia caecimuris (cae.ci.mu’ris. L.
n. caecum caecum; L. n. muris of a mouse; N. L. gen. n. caecimuris from the caecum
of a mouse). The closest phylogenomic neighbour is Blautia wexlerae and the dDDH
value between both genomes is 25.6%. The G+C content difference between strain
SJ18T and Blautia wexlerae is 1.6%.
The cells are coccoid and oval-shaped. It is a Gram-positive, strictly anaerobic
bacterium. It is positive for α- and β-galactosidase, α-glucosidase, α-fucosidase,
arginine arylamidase and leucine arylamidase (Rapid ID32A). It produces acid from
D-glucose, D-lactose, D-saccharose, D-maltose, salicin, D-xylose, L-arabinose,
D-rafﬁnose, D-trehalose and L-rhamnose (Api 20A).
Nine alpha-amylases, which can be assigned to glycoside hydrolase family GH13
and catalyse the glycosidic linkage of glycosides, are detectable within the genome. All
enzymes responsible for degradation of glycogen/starch are present: GlgX, a glycogen
branching enzyme (E.C. 2.4.1.18; several copies), glycogenphosphorylase (E.C. 2.4.1.1,
Prokka_03262), maltodextrinphosphorylase (E.C. 2.4.1.1, Prokka_02645) and
phospoglucomutase (E.C. 5.4.2.2, Prokka_01686). A second pathway for glycogen
degradation to D-glycopyranose 6-phosphate is also present: the ﬁrst two steps are
identical, but then maltotetraose is converted to maltotriose (E.C. 2.4.1.1,
Prokka_02645), which is degraded to D-glycopyranose 6-phosphate: amylomaltase
(E.C. 2.1.4.25, Prokka_02646); glucokinase (E.C. 2.7.1.2, Prokka_03476). The
glucokinase is also involved in degradation of trehalose. Trehalose uptake is carried out
by a trehalose-speciﬁc phosphotransferase system (PTS; Prokka_03240). The strain
also possesses trehalose import proteins (Prokka_02649, 00179), transport system
permease (Prokka_0062, 0067) and the operon repressor TreR (03239).
Chitobiose can also be transported and is subsequently phosphorylated to
N,N′-diacetylchitobiose 6′-phosphate (E.C. 2.4.1.280; several copies), which is
deacetylated (Prokka_03287) and hydrolysed by a glycosyl hydrolase to
D-glucosamine andN-acetyl-D-glucosamine 6-phosphate (E.C. 3.2.1.86, Prokka_00121).
N-acetyl-D-glucosamine 6-phosphate can enter the N-acetylglucosamine degradation I
pathway for conversion to β-D-fructofuranose 6-phosphate, which may enter glycolysis
(E.C. 3.5.1.25, N-acetylglucosamine 6-phosphate deacetylase, Prokka_00134;
glucosamine 6-phosphate deaminase, Prokka_03782).
Xylose can be bound and imported by XylF and XylG proteins (Prokka_01553,
01554) in combination with the transport permease XylH (Prokka_01554). The
xylose operon is regulated by XylR (Prokka_03489). D-xylopyranose is converted to
D-xylulose by an isomerase (Prokka_02659) and phosphorylated to D-xylulose-5-
phosphate by a kinase (Prokka_01743). The latter compound may enter the pentose
phosphate pathway to form D-glyceraldehyde-3-phosphate (epimerase E.C. 5.1.3.1,
Prokka_00665; isomerase E.C. 5.3.1.6, Prokka_02662; transketolase E.C. 2.2.1.1,
several copies; transaldolase E.C. 2.2.1.2, Prokka_01937).
Lactose can be hydrolysed by a β-D-galactosidase (E.C. 3.2.1.23, Prokka_03707).
Several amino acids can be degraded: arginine decarboxylase (E.C. 4.1.1.19,
Prokka_03783), L-serine ammonia lyase (E.C. 4.3.1.17, Prokka_02259), threonine
ammonia lyase (E.C. 4.3.1.19, Prokka_03091), methionine γ-lyase (E.C. 4.4.1.11,
Prokka_00824) and D-cysteine (E.C. 4.4.1.15, Prokka_02595).
Major cellular fatty acids comprise C18:0 (26.9%), C12:0 (22.5%), iso I-C19:1 (15.5%),
C16:0 (13.1%), iso -C17:1/anteiso-C17:1 (8.8%) and C14:0 (4.8%). The diagnostic amino
acid of the peptidoglycan type is meso-diaminopimelic acid. The G+C content of
genomic DNA is 43.0 mol%. The type strain is SJ18T (=DSM 29492T = KCTC 15541T).
Description of Cuneatibacter gen. nov. Cuneatibacter (Cu.ne.a.ti.bac’ter. L adj
cuneatus wedge-shaped; L. masc. n. bacter rod; N.L. masc. n. Cuneatibacter a rod-
shaped bacterium with wedge-shaped ends). The nearest phylogenomic neighbours
are Clostridium clostridioforme and Clostridium symbosium. It is placed into the
Lachnospiraceae cluster, apart from the type species of the genus Clostridium,
Clostridium butyricum. POCP between C. butyricum and C. clostridioforme or
C. symbosium is 39.9% and 39.7%, respectively. These low values conﬁrm that both
are not members of the Clostridium sensu stricto cluster. POCP between the genome
of C. clostridioforme and C. symbosium is 36.5% and dDDH is 22.2%. The dDDH
values between strain BARN-424-CC-10T and C. clostridioforme or C. symbosium are
21.6% or 22.3%, respectively. The difference in G+C content of DNA is 1.4% for both
comparisons. All these values conﬁrm the separate genus status of the isolate. The
G+C content of genomic DNA of the type strain is 49.1 mol%. The type species is
Cuneatibacter caecimuris.
Description of Cuneatibacter caecimuris sp. nov. Cuneatibacter caecimuris (cae.ci.
mu’ris. L. n. caecum caecum; L. n. muris of a mouse; N. L. gen. n. caecimuris from
the caecum of a mouse). Its cells are small rods with tapered ends, 2–3 µm in length.
It is Gram-positive and strictly anaerobic. It is positive for α- and β-galactosidase,
β-glucoronidase, α- and β-glucosidase and α-arabinosidase (Rapid ID32A), esculin
hydrolysis and acidiﬁcation from L-rhamnose (Api 20A).
β-D-galactose can be degraded to form UDP-glucose. In a ﬁrst step, the aldose-1-
epimerase converts β-D-galactose to α-D-galactose (E.C. 5.1.3.3, Prokka_02857),
which is subsequently phosphorylated by a galactokinase (E.C. 2.7.1.6,
Prokka_00204). As a result of galactose 1-phosphate uridinyltransferase activity
(E.C. 2.7.7.12, Prokka_00203), UDP-α-galactose is formed and rearranged to
UDP-glucose (E.C. 00996; Prokka_0096).
N-acetyl-D-glucosamine can be degraded to form D-fructose 6-phosphate:
N-acetyl-glucosamine 6-phosphate deacetylase (E.C. 3.5.1.25, Prokka_01387);
glucosamine 6-phosphate isomerase (E.C. 3.5.99.6, Prokka_01388).
L-arabinose can be degraded to D-xylulose 5-phosphate due to L-arabinose
isomerase activity (E.C. 5.3.1.4, Prokka_00574) and L-ribulose-5-phosphate
4-epimerase (E.C. 5.1.3.4; Prokka_01532). D-xylulose 5-phosphate may also be
formed via degradation of D-xylose (E.C. 5.1.3.1.5, Prokka_01741; E.C. 2.7.1.17,
Prokka_01860), which may enter the pentose phosphate pathway to generate
D-fructose 6-phosphate (E.C. 2.2.1.1, transketolase, Prokka_00573; E.C. 2.2.1.2
transaldolase, Prokka_00768) and D-erythrose 4-phosphate. The latter can be
converted to D-glyceraldehyde 3-phosphate by a transketolase activity, which may be
converted to phosphoenolpyruvate (E.C. 1.2.1.12, Prokka_02031; E.C. 4.4.1.12,
Prokka_02034; E.C. 2.7.2.3, Prokka_02032; E.C.5.4.2.12, Prokka_02345; E.C.
4.2.1.11, Prokka_02345). Phosphoenolpyruvate can be transformed to L-lactate
(E.C. 2.7.1.40, pyruvate kinase, Prokka_01764; E.C. 1.1.1.27, dehydrogenase,
Prokka_00578). D-erythrose 4-phosphate can also enter the chorismate biosynthesis
pathway (all enzymes of this pathway are present in the genome of strain BARN-
424-CC-10): E.C. 2.5.1.54, Prokka_00306; E.C. 4.2.3.4, Prokka_0226; E.C. 4.2.1.10,
Prokka_00678; E.C. 1.1.24, Prokka_00680; E.C. 2.7.1.71, Prokka_03116; E.C.
2.5.1.19, Prokka_00308; E.C. 4.2.3.5, Prokka_00530.
The glycosyl hydrolases of family GH 28 (E.C. 3.2.1.15, polygalacturoronase),
GH 78 (α-L-rhamnosidase) and GH105 (E.C. 4.2.2.23, rhamnogalacturonyl
hydrolase) are involved in the degradation of pectin at the beginning of the pathway
followed by activity of YesY (E.C. 3.1.1, Prokka_02705) and YesR (E.C. 3.2.1.172,
Prokka_00382). The resulting 4-deoxy-L-threo-hex-4-enopyranuronate can be
degraded by action of E.C. 5.3.1.17, isomerase, Prokka_01284; E.C. 1.1.1.67,
dehydrogenase, Prokka_00822; E.C. 2.7.1.45, kinase, Prokka_00327 and aldolase
(Prokka_00328). The end products are D-glyceraldehyde 3-phosphate and pyruvate.
A pathway for degradation of glycogen is detectable and includes the following
reactions: phosphorylase (E.C. 2.4.1.1, Prokka_02446); 4-α-glucanotransferase (E.C.
2.4.1.25, Prokka_03092); α-glucosidase (E.C. 3.2.1.33; Prokka_02446); phosphorylase
(E.C. 2.4.1.1, Prokka_02446) and phosphoglucomutase (E.C. 5.4.2.2, Prokka_02715).
The end product is D-glucose 6-phosphate, which may enter glycolysis.
The predominant cellular fatty acid is C16:0 (43.4%). Other fatty acids detectable
with the MIDI system are iso-C17:1/anteiso-C17:1 (10.1%), iso-C15:1/C13:0 OH (9.0%),
C17:1 ω8c (8.3%) and C14:0 (6.2%). Meso-diaminopimelic acid is absent. The type
strain is BARN-424-CC-10T (=DSM29486T = KCTC 15539T).
Description of Enterorhabdus muris sp. nov. Enterorhabdus muris (mu’ris L. gen.
n. muris of a mouse). Phylogenomic analysis places strain WCA-131-CoC-2T into
the Enterorhabdus cluster. The dDDH value between the genome of E. mucosicola
and E. caecimuris is 35.3% and between strain WCA-131-CoC-2T, E. mucosicola and
E. caecimuris is 38.3 and 43.1%, respectively. These values clearly conﬁrm the
separate species status of strain WCA-131-CoC-2T.
The cells are rods, up to 5 µm in length, and are strictly anaerobic. The substrate
proﬁle in Api 20A kit is negative. Arginine hydrolase activity is detected with Rapid
ID 32A. Arginine can de degraded to CO2 by activity of the following enzymes:
E.C. 3.5.3.6, deaminase, Prokka_01275; E.C. 2.1.3.3, carbamoyltransferase,
Prokka_01150; E.C. 2.7.2.2, carbamate kinase, Prokka_00063. L-serine can be
degraded to pyruvate: E.C. 4.3.1.17, Prokka_02086. Formate can be converted to
5,10-methylenetetrahydrofolate or to CO2 (E.C. 6.3.4.3, ligase, Prokka_01739;
E.C. 3.5.4.9, cyclohydrolase, Prokka_01741; E.C. 1.5.1.5, reductase; E.C. 1.2.1.2,
Prokka_00906). Alkylnitronate can be metabolized to nitrite (E.C. 1.13.12.16,
Prokka_00873). L-rhamnose can be degraded to form L-lactaldehyde
dihydroxyacetone phosphate (E.C. 5.3.1.14, isomerase, Prokka_00371; E.C. 2.7.1.5,
rhamnulokinase, Prokka_00372; E.C. 4.1.2.19, aldolase, Prokka_00370). All
enzymes of the pentose phosphate pathway are present: E.C. 5.3.1.6, Prokka_01108;
E.C. 5.3.1.1, Prokka_01187; E.C. 2.2.1.1, Prokka_02151; E.C. 2.2.1.2, Prokka_00123;
E.C. 2.1.1, Prokka_02151.
The major cellular fatty acids are C18:1 ω9c (14.3%), iso-C17:1/anteiso-C17:1
(12.1%), anteiso-C15:0 (12.3%), iso-C15:0 (7.9%), C16:0 (13.8%), C18:0 (7.5%), iso-C14:0
(5.1%) and C14:0 (3.7%). The diagnostic amino acid of the peptidoglycan type is
meso-diaminopimelic acid. The G+C content of genomic DNA is 65.1 mol%.
The type strain is strain WCA-131-CoC-2T (=DSM 29508T = KCTC 15543T).
Description of Extibacter gen. nov. Extibacter (Ex.ti.bac’ter. L. neut. n. extum
bowels or entrails of an animal; N.L. masc. n. bacter rod; N.L. masc. n. Extibacter a
rod isolated from the intestine). The nearest phylogenetic neighbour is Clostridium
hylemonae. POCP between the genome of C. hylemonae and Clostridium butyricum,
the type species of the genus Clostridium, is only 14.3%, indicating the separate
genus status of C. hylemonae. The dDDH value between both Clostridium
genomes is 28.4% and between C. hylemonae and strain 40cc-B5824-ARET 23.8%.
The G+C content of genomic DNA of the type strain is 47.9 mol%. Type species
is Extibacter muris.
Description of Extibacter muris sp. nov. Extibacter muris (mu’ris, L. gen. n. muris
of a mouse). Cells stain Gram-positive, and are strictly anaerobic rods up to 3 µm in
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length. It is positive for β-galactosidase and proline arylamidase (Rapid ID32A) and
acidiﬁcation from D-glucose, D-lactose, L-rhamnose and xylose (Api20A).
Fructose 6-phosphate can be converted to acetyl-CoA via phosphoenolpyruvate.
ABC transporters for Na+, phosphate, cobalt, biotin, rafﬁnose andmelibiose are present.
Trehalose can be converted via phosphoenolpyruvate to acetyl-CoA (E.C. 2.4.1.64,
Prokka_03664). A β-galactosidase (E.C. 3.2.1.23, Prokka_01478), which may hydrolyse
lactose, and all components of the xylose operon are present: xylose isomerase
(Prokka_02910); 12 copies of xylB (kinase); the transport binding proteins XylF
(Prokka_02319) and XylG (Prokka_02978); and the membrane transporter XylH
(Prokka_02977). The xylFGH operon is positively regulated by XylR (Prokka_03195).
Degradation of glycogen/starch starts with a glycogenphosphorylase (E.C. 2.4.1.1;
Prokka_00499, 02735), which releases α-D-glucopyranose 1-phosphate. The 1,6-
glucohydrolase (E.C. 3.2.1, Prokka_02220) produces a debranched α-limit dextrin
and shorter maltotetraose units ﬁrst. α-D-glucopyranose 1-phosphate is then
converted to D-glucopryanose 6-phosphate due to the activity of a
phosphoglucomutase (E.C. 5.4.2.2, Prokka_00906). A maltodextrin phosphorylase
cleaves maltodextrin to α-D-glucose 1-phosphate after several steps (E.C. 2.4.1.25,
amylomaltase; Prokka_03040) and glucokinase activity (E.C. 2.7.1.2, Prokka_01911).
Several amino acids can be degraded and the enzymes involved are highly
speciﬁc to their substrates: arginine decarboxylase (E.C. 4.1.1.19, Prokka_00457),
L-serine ammonia lyase (E.C. 4.3.1.17, Prokka_00547), D-serine ammonia lyase (E.C.
4.3.1.18, Prokka_01317), threonine ammonia lyase (E.C. 4.3.1.19, Prokka_03487),
methionine γ-lyase (E.C. 4.4.1.11, Prokka_01328).
Predominant fatty acids are C16:0 (25.3%), C14:0 (23.7%), iso-C17:1/anteiso-C17:1
(14.0%) and iso-C15:1/C13:0 OH (10.0%). Meso-diaminopimelic acid is absent. The
type strain is 40ccB-5824-ARET (=DSM 28560T = KCTC 15546T).
Description of Flintibacter gen. nov. Flintibacter (Flin.ti.bac’ter. N.L. n. Flint name
Flint; L. masc. n. bacter rod; N.L. masc. n. Flintibacter rod-shaped bacterium named
after Professor Harry J. Flint, a microbiologist from Aberdeen, UK, who dedicated
his career to the investigation of gut bacteria, especially butyrate producers and their
role in health and disease). The nearest phylogenomic neighbours are Intestimonas
butyriciproducens, Pseudoﬂavonifractor capillosus and Flavonifractor plautii.
Corresponding dDDH values are 24.4, 24.7 and 24.7%, respectively. The respective
differences in G+C content of DNA are 1.4, 1.1 and 3.0%. The dDDH value between
P. capillosus and F. plautii is 26.6% (and the POCP is 42.7%), and the dDDH
between the genomes of I. butyriciproducens and F. plautii is 23.3%. The G+C
content of genomic DNA of the type strain is 58 mol%. The type species is
Flintibacter butyricum.
Description of Flintibacter butyricum sp. nov. Flintibacter butyricum (N.L. neut.
adj. butyricum related to butter, butyric, referring to the production of the short-
chain fatty acid butyrate). It is strictly anaerobic, non-motile, non-spore forming,
and catalase and oxidase negative, and stains Gram-negative. It grows at
temperatures between 30 and 40 °C and in RCM broth containing up to 1% NaCl.
It forms long ﬁlaments that separate into small irregular needle-like rods. It is
negative for all reactions in Api 20A, and is positive for α-galactosidase in Rapid
ID32A. It produces butyrate and acetate when grown in the presence of amino acids
glutamine and glutamate, but there is no growth on leucine, lysine, arginine,
glutamic and aspartic acid.
L-glutamate can be fermented by the hydroxyglutarate pathway to crotonyl-
CoA, and further to butanoate (butyrate) and acetate. The following reactions are
included in this pathway: E.C. 1.4.1.2, dehydrogenase, Prokka_00142; E.C. 2.8.3.12,
transferase; Prokka_01566, 01567; E.C. 4.1.1.70, decarboxylase, Prokka_02670;
E.C.1.1.1.157, 3-hydroxybutyryl-CoA dehydrogenase, Prokka_00188, 01591, 01835.
Pyruvate can be converted to lactate (E.C. 1.1.1.27, Prokka_00634) or
dehydrogenized (Prokka_00041) to form acetyl-CoA, which can be used to form
acetate (E.C. 2.3.1.8, acetyl transferase, Prokka_00599).
Rafﬁnose may be hydrolysed (E.C. 3.2.1.22, α-galactosidase) to form α-D-
galactose and β-D-glucose. Melibiose can also be hydrolysed to α-D-galactose to form
β-D-glucose 6-phosphate: E.C. 5.1.3.3, aldose epimerase, Prokka_02811; E.C. 2.7.1.6,
galactokinase, Prokka_0072; E.C. 2.7.7.12, uridyltransferase, Prokka_0773; E.C.
1.3.2, UDP-glucose-4-epimerase, Prokka_01687; E.C. 5.4.2.2, phosphoglucomutase,
Prokka_00685, 00705.
N-acetyl-glucosamine can be deacetylated by E.C. 3.5.1.25 (Prokka_01697) and
converted to β-D-fructofuranose 6-phosphate by E.C. 3.5.99.6 (Prokka_01696).
Fructofuranose 6-phosphate can also be formed from D-mannose, which is picked
up by a PTS system. D-mannose 6-phosphate is converted to fructofuranose
6-phosphate via isomerase E.C. 5.3.1.8 (Prokka_01350).
A cellulase that forms cellobiose is detectable in the genome (E.C. 3.2.1.4,
Prokka_02188), and cellobiose can be converted to a glucopyranose by glucosidase
activity (E.C. 3.2.1.21, Prokka_02301).
Glycogen/starch can be degraded to form α-D-glucose 6-phosphate from
maltotetraose or β-D-glucose 6-phosphate. The ﬁrst reactions include E.C. 2.4.1.1
(Prokka_00610, 02033) and E.C. 3.2.1 (Prokka_03259), followed by E.C. 2.4.1.1
again and phosphoglucomutase activity (E.C. 5.4.2.2, Prokka_00685). Maltotriose
can be converted to β-D-glucose 6-phosphate by glucosidase activity (E.C. 3.2.1.20,
Prokka_03810), 4-α-glucotransferase (E.C. 2.4.1.25, Prokka _02266, 00609) and
glucokinase K activity (E.C. 2.7.1.2, Prokka_01053, 01439).
Main cellular fatty acids are iso C17:1/anteiso C17:1 (16.1%), iso-C19:1
(14.8%), C18:1 ω9c (13.5%), C12:0 (12.2%), C14:0 (11.4%), C16:0 (11.2%) and
C18:0 (8.8%). The G+C content of the genomic DNA is 58 mol%. The type strain
is BLS21T (=DSM 27579T = KCTC 15544T).
Description of Frisingicoccus gen. nov. Frisingicoccus (Fri.sing.coc’cus. L. fem. n.
Frisinga the Roman name for the city of Freising; N.L. masc. n. coccus coccus; N.L.
masc. n. Frisingicoccus; the type strain of the type species grows as coccobacilli and
was originally isolated in the German city Freising). In the phylogenomic tree, strain
PG-426-CC-1T branches before the group composed of Cuneatibacter muris DSM
29486T, Clostridium clostridioforme and Clostridium symbosium. The dDDH
between both Clostridium genomes is 22.2%. dDDH of strain PG-426-CC-1T against
Cun. muris is 21.9% and against C. clostridioforme and C. symbosium 23.3 and
22.5%, respectively. The respective differences in genomic G+C content are 5.4,
5.4 and 4.0%, respectively. The G+C content of genomic DNA of the type strain is
43.7 mol%. The type species is Frisingicoccus caecimuris.
Description of Frisingicoccus caecimuris sp. nov. Frisingicoccus caecimuris (cae.ci.
mu’ris. L. n. caecum caecum; L. n. muris of a mouse; N. L. gen. n. caecimuris from
the caecum of a mouse). The cells are rods that separate into coccoid forms, and are
strictly anaerobic. All Api 20A reactions are negative. It is positive for arginine and
leucine arylamidase in Rapid ID 32A. It is able to utilize various amino acids by
decarboxylation or non-oxidative deamination: arginine (E.C. 4.1.1.19,
Prokka_01494); aspartate (E.C. 4.1.1.11, Prokka_00650); serine (E.C. 4.3.1.17,
Prokka_00515); and threonine (E.C. 4.1.3.19, Prokka_02055). L-glutamate can be
degraded to L-aspartate by transaminase activity (E. 2.6.1.1, Prokka-02564), which is
metabolized to fumarate and NH3 (E.C. 4.3.1.1, aspartate ammonia lyase,
Prokka_00708).
A total of 50 ABC transporters can be detected in the genome of strain PG-426-
CC-1, including those for phosphate, iron, branched chain amino acids,
oligopeptides and D-methionine. Allose can be converted to β-D-fructofuranose
6-phosphate, which enters glycolysis (E.C. 2.7.1.55, D-allose kinase, Prokka_00524;
E.C. 5.3.1.–, isomerase Prokka_00367). N-acetylglucosamine 6-phosphate may enter
the cell by a PTS system and can subsequently be converted to D-glucosamine-6-
phosphate by deacetylation and to β-D-fructofuranose 6-phosphate by deamination
(E.C. 3.1.5.25, Prokka_00143; PTS phosphor carrier protein, Prokka_00706; PTS
phosphorylation component, Prokka_00564; E.C. 3.5.99.6, Prokka_00155).
β-D-fructofuranose 6-phosphate can then enter glycolysis.
The cellular fatty acids are C18:1 ω9c (22.3%), C16:0 (22.1%), iso-C17:1/anteiso-C17:1
(10.3%) and C18:0 (10.0%), with low amounts of C14:0 (7.5%), iso-C15:1/C13:0 3-OH
(4.6%) and an unknown component (4.7%; RT 14.949). Meso-diaminopimelic
acid is absent. The G+C content of genomic DNA is 43.7 mol%. The type strain
is PG-426-CC-1T (=DSM 28559T = KCTC 15538T).
Description of Irregularibacter gen. nov. Irregularibacter (Ir.re.gu.la.ri.bac’ter. L. adj.
irrgeularis irregular; N.L. masc. n. bacter rod; N.L. masc. n. Irregularibacter an irregular
rod-shaped bacterium). Phylogenomic analysis places strain 2PG-426-CC-4.2T into
a separate lineage within the Firmicutes. dDDH values in comparison to the three
closest phylogenomic neighbours (Anaerofustis stercorihominis, Eubacterium limosum
and Pseudoramibacter alactolyticus) are 25.5, 28.5 and 31.5%, respectively. The
respective differences in G+C content of DNA are 2.4, 11.7 and 15.9%. The RSH is
larger than within the neighboured group that already contains three distinct genera.
Hence, we propose to place the strain into a novel genus. The G+C content of genomic
DNA of the type strain is 35.8 mol%. The type species is Irregularibacter muris.
Description of Irregularibacter muris sp. nov. Irregularibacter muris (mu’ris
L. gen. n. muris of a mouse). Cells are rods that can form long ﬁlaments of up to
10 µm. It is positive for indole production (Rapid ID 32A) and esculin hydrolysis
(Api 20A). All other reactions are negative.
Glutamate can be degraded to n-butanoate including the following reactions:
E.C. 1.4.1.2, dehydrogenase, Prokka_00372; E.C.2.8.3.12, CoA-transferase,
Prokka_02420; CoA-dehydratase, Prokka_0065; E.C. 1.1.1.157, butyryl-CoA-
dehydrogenase, Prokka_02002, 02766; E.C. 2.8.3.8, acetate CoA-transferase,
Prokka_02840, 00642. Glycerol can be converted to glycerol-3-phosphate
(E.C. 2.7.1.30, kinase, Prokka_02919, 00840) and further metabolized to form
glycerone phosphate, which may enter glycolysis (E.C. 1.1.1.94, glycerol
3-phosphate dehydrogenase, Prokka_00228).
Glycogen biosynthesis from ADP-D-glucose is possible, including the following
enzyme activities: E.C. 2.4.1.21, Prokka_02946; E.C. 2.4.1.18, Prokka_02943;
E.C. 2.7.7.27, Prokka_02944; E.C. 5.4.2.2, phosphoglucomutase, Prokka_02192.
It is able to ferment amino acids: arginine (E.C. 4.1.1.19, Prokka_00095);
threonine (E.C. 4.3.1.19, Prokka_00046); L-serine (E.C. 4.3.1.17, Prokka_00048).
L-cysteine may be converted to pyruvate, NH3 and H2S (E.C. 4.4.1.1,
Prokka_01832). Tryptophan may also be metabolized to indole, pyruvate and
ammonium (E.C. 4.1.99.1; Prokka_00116).
The cellular fatty acids proﬁle comprises C18:1 ω9c (23.0%), C16:0 (19.6%), C14:0
(18.5%) and C18:0 (12.8%) as major components; C12:0 (8.7%), C16:1 w7c/iso-C15:0 2-OH
(5.3%) and C10:0 (4.9%) also occur.Meso-diaminopimelic acid is absent. The type strain
is 2PG-426-CC-4.2T (=DSM 28593T = KCTC 15548T).
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Description of Longicatena gen. nov. Longicatena (Lon.gi.ca.te’na. L. adj. longus
long; L. fem. n. catena chain, N.L. fem. n. Longicatena the type strain of the type
species grows as long chains). The closest phylogenomic neighbour of strain
PG-426-CC-2T is Clostridium innocuum and the corresponding dDDH is 21%.
The dDDH between the isolate and the type species of the genus Clostridium,
Clostridium butyricum, is 27.8%. The respective difference in genomic G+C content
is 9.3%. Eubacterium dolichum is distantly related to strain PG-426-CC-2T, as is the
type species of the genus Eubacterium, Eubacterium limosum, with which strain
PG-426-CC-2T shares a dDDH of only 30.7%. The corresponding difference in
genomic G+C content is 9.7%. This value supports the creation of a novel genus to
accommodate strain PG-426-CC-2T. The G+C content of genomic DNA of the type
strain is 37.8 mol%. The type species is Longicatena muris.
Description of Longicatena caecimuris sp. nov. Longicatena caecimuris (cae.ci.
mu’ris. L. n. caecum caecum; L. n. muris of a mouse; N. L. gen. n. caecimuris from
the caecum of a mouse). The cells are rods, forming long ﬁlaments. All reactions in
Rapid ID 32A are negative, but it is positive for esculin hydrolysis in Api 20A.
The complete pathway for formaldehyde oxidation is present, starting with
D-ribulose 5-phosphate and formaldehyde to form hexulose 6-phosphate:
E.C. 4.1.2.43, hexulose 6-phosphate synthase, Prokka_00565; E.C. 5.3.1.27,
hexuloisomerase, Prokka_00566; E.C. 5.3.1.9, glucose 6-phosphate isomerase,
Prokka_01514; E.C. 1.1.1.49, glucose 6-phosphate dehydrogenase, Prokka_02255;
E.C. 1.1.31 phosphoglucanolactonase, Prokka_02253; E.C. 1.1.1.343,
phosphogluconate dehydrogenase, Prokka_02254.
Pyruvate can be converted to lactate (E.C. 1.1.1.27, Prokka 01579). L-serine and
L-threonine can be fermented (E.C. 43, 1.17, Prokka_02192; E.C. 4.3.1.19,
Prokka_01200). Several enzymes involved in the degradation of glycogen are
available: E.C. 2.4.1, phosphorylase, Prokka_01627, 02537; E.C. 2.4.1.25, transferase,
Prokka_01628; E.C. 5.4.2.2, phosphoglucomutase, Prokka_01780.
The predominant fatty acid is C18:1 ω9c (77.4%), and minor fatty acids are
C18:1 ω7c (5.7%), C16:0 (4.6%), iso-C19:0 (2.9%), C18:1-2OH (2.0%) and C18:0 (1.9%).
Meso- diaminopimelic acid is absent. The type strain is PG-426-CC-2T (=DSM
29481T = KCTC 15535T).
Description of Longicella gen. nov. Longicella (L. adj. longus long; L. f. cella the cell;
Longicella growing as long cells, ﬁlaments). Phylogenomic analysis places strain
MT10-315-CC-1.2-2T into the Erysipelotrichaceae cluster, distantly related to all
other members of this cluster. The RSH of strain MT10-315-CC-1.2-2T is larger than
within the neighboured group, which includes four distinct genera (Catenibacterium
mitsuokai, Kandleria vitulina, Sharpea azabuensis and Eggerthia catenaformis). The
nearest neighbour is ‘Stoqueﬁchus massiliensis’, which currently has no standing in
nomenclature and was therefore not included in the analysis. We thus propose that
strain MT10-315-CC-1.2-2T represents a novel genus. The G+C content of genomic
DNA is 30.8 mol%. The type species is Longicella muris.
Description of Longicella muris sp. nov. Longicella muris (mu’ris L. gen. n.muris of
a mouse). It is able to form long ﬁlaments >20 µm in length, and is strictly anaerobic.
It is positive for β-galactosidase, β-glucoronidase, N-acetyl glucosamine and
pyroglutamic acid arylamidase (Rapid ID 32A). All reactions for acidiﬁcation of
carbohydrates are negative (Api 20A).
The genome contains 30 glucosidases of family GH1. Arbutin and salicin can be
converted to β-D-glucose-6-phosphate (E.C. 2.7.1.69, phosphotransferase,
Prokka_00070; 3.2.1.86, glucosidase, Prokka_00223). Sucrose can be degraded to
form β-D-fructofuranose-6-phosphate (E.C. 3.2.1.26, hydrolase, Prokka_01036;
E.C. 2.7.1.2, glucokinase, Prokka_00474; E.C. 5.3.1.9, Prokka_00116; or directly by
fructokinase activity (E.C. 2.7.1.4; Prokka_00908). Rhamnose can be converted to
L-lactaldehyde dihydroacetone, which may enter glycolysis (E.C. 5.3.1.14, isomerase,
Prokka_00519; E.C. 2.7.1.5, kinase, Prokka_00518; E.C. 4.1.2.19, aldolase,
Prokka_00520). β-D-galactose can be converted to glucose 6-phopshate, which can
also enter glycolysis (E.C. 5.1.3.3, epimerase, Prokka_02823; E.C. 2.7.1.6,
galactokinase, Prokka_02824; E.C. 2.7.7.12, transferase, Prokka_02822).
Lactose can be used to form β-D-galactose and β-D-glucose (E.C. 3.2.1.23,
Prokka_00851).
A type II secretion pathway including eps E, F, H is present. The following
enzymes for degradation of glycogen are also present: E.C. 2.4.1.1, phosphorylase,
Prokka_02190; E.C. 2.4.1.25, glucotransferase, Prokka_01371; E.C. 3.2.1.10, 1,6-
glucosidase Prokka_02259, 03135; E.C.5.4.2.2, phosphoglucomutase, Prokka_02540.
The main fatty acids are C16:0 (30.1%), C18:1 ω9c (15.4%), C18:1 ω7c (9.9%),
C16:1 ω7c/iso-C15:0-OH (8.9%), C18:0 (6.6%) and C16:1 ω11c (5.4%). The diagnostic
amino acid of the peptidoglycan type is meso-diaminopimelic acid. The type
strain is MT10-315-CC-1.2-2T (=DSM 29487 T = KCTC 15536T).
Description of Muribaculum gen. nov. Muribaculum (L. n. mus, muris a mouse;
L. n. baculum rod, stick; Muribaculum rod-shaped bacterium from mice).
Phylogenomic analysis places strain YL27T into a separate lineage nearby the
genera Coprobacter and Barnesiella. The nearest phylogenetic neighbour as
determined by 16S rRNA gene sequence analysis is Barnesiella intestinihomis,
showing only 86.2% sequence similarity, which is below the proposed threshold of
86.5% for families75. dDDH values between strain YL27T and the genomes of
Coprobacter fastidiosus, B. intestinihominis and Barnesiella viscericola are 23.8, 23.4
and 23.4%, respectively. Corresponding differences in genomic G+C content are
11.6, 6.0 and 1.7%. The G+C content of genomic DNA of the type strain is
49.9 mol%. The type species is Muribaculum intestinale.
Description ofMuribaculum intestinale sp. nov.Muribaculum intestinale (in.tes.ti.
na’le. N.L. neut. adj. intestinale pertaining to the intestines). It is strictly anaerobic. It
is positive for α-galactosidase, β-galactosidase, N-acetyl-β-glucosamidase, alkaline
phosphatase, leucyl glycine arylamidase and alanine arylamidase (Rapid ID 32A),
and is negative for all reactions in Api 20A.
Galactose can be degraded to form β-D-glucose 6-phosphate (E.C. 5.1.3.3,
epimerase, Prokka_01653; E.C. 2.7.1.6, kinase, Prokka_01654; E.C. 5.1.3.2,
epimerase, Prokka_02048; E.C. 5.4.2.2, phosphoglucomutase, Prokka_00248).
Pectin can be depolymerized to D-galactopyranuronate (E.C. 3.1.1.11, pectin
esterase, Prokka_02543; E.C. 3.2.1.82, galacturonidase, Prokka_02522; E.C. 4.2.2.2,
pectic acid lyase PL10, Prokka_00090).
The main cellular fatty acid is anteiso-C15:0 (59.9%); C16:0-30H (8.3%),
iso-C15:0 (5.6%), C14:0 (3.9%) and C15:0 3-OH (3.3%) are detected in minor amounts.
Meso-diaminopimelic acid is absent. The type strain is YL27T (=DSM 28989T =
KCTC 15537T).
Description of Muricomes gen. nov. Muricomes (Mu.ri.co’mes, L.n. mus, muris
mouse; L.n. comes a companion; N.L. masc. n.,Muricomes a companion of a mouse).
Phylogenomic analysis places strain 2-PG-424-CC-1T into a separate lineage with a
RSH clearly larger than within the neighboured group holding species from two
distinct genera: Clostridium oroticum, Eubacterium contortum and Eubacterium
ﬁssicatena. These species share dDDH values of 20.1, 20.0 and 20.1% with strain
2-PG-424-CC-1T, respectively. These data indicate that strain 2-PG-424-CC-1T
represents a novel genus. C. oroticum is characterized by dDDH values of 21.0 and
21.2% with E. contortum and E. ﬁssicatena, respectively. The two Eubacterium
species show a dDDH of 27.6%. They are distantly related to the type species of the
genus Eubacterium (Eubacterium limosum) and must be reclassiﬁed in future.
The G+C content of genomic DNA of the type strain is 43.1 mol%. The type species
is Muricomes intestini.
Description ofMuricomes intestini sp. nov.Muricomes intestini (in.tes’ti.ni. L. gen.
n. intestini of the gut, referring to the ecosystem of origin of the type strain).
Its cells are Gram-positive rods able to grow under anaerobic conditions, and it is
positive for α-glucosidase and proline arylamidase (Rapid ID32A). It is able to utilize
L-arabinose, D-glucose, D-mannitol, D-maltose, D-mannose, L-rhamnose, D-sorbitol
and D-xylose (Api 20A).
Carbohydrate binding modules (CBM) with carbohydrate-binding activities are
detectable within the genome for xylan/mannan (CBM 35 family; Prokka_00901)
and chitin (CBM 50 family, Prokka_01736). Chitin can be degraded to
N-acetylglucosamine by a diacetylchitobiase (E.C. 2.4.1.280, Prokka_01771).
Subsequently, N-acetyl-glucosamine 6-phosphate is formed by the activity of a
phosphotransferase system and can be transformed to D-glucosamine 6-phosphate
due to deacetylase activity (E.C. 3.5.1.25, Prokka_02773). Deamination (E.C.
3.5.99.6, Prokka_01084) leads to formation of D-fructofuranose 6-phosphate.
Cellulose can be degraded (E.C. 3.2.1.4, Prokka_00599) to form more soluble
components. An arabinofuranidase (E.C. 3.2.1.55, Prokka_02409) can extract
arabinose and xylan to produce xylodextrin and subsequently xylotriose and
xylobiose (E.C. 3.2.1.54, dextrinase, Prokka_02684).
All enzymes for degradation of glycogen to α-glucose 6-phosphate are detectable
within the genome: glycogenphosphorylase (E.C. 2.4.1.1, Prokka_01745);
α-1,6 glucohydrolase (E.C. 3.2.1.111, Prokka_00827); maltodextrinphosphorylase
(E.C. 2.4.1.1, Prokka_02991); and a phosphoglucomutase (E.C. 5.4.2.2,
Prokka_01606). A second pathway for glycogen degradation to D-glycopyranose
6-phosphate is also present: the ﬁrst two steps are as above, but maltotetraose is then
converted to maltotriose (E.C. 2.4.1.1, phosphorylase; Prokka_02991), which is
degraded to D-glycopyranose 6-phosphate (E.C. 2.1.4.25, amylomaltase,
Prokka_02987; E.C. 2.7.1.1, glucokinase, Prokka_0362).
β-D-glucose 6-phosphate and β-D-fructofuranose 6-phosphate can be converted
to phosphoenolpyruvate and pyruvate via glycolysis. Phosphoenolpyruvate and
pyruvate can be utilized within a mixed acid fermentation with acetate, CO2 and H2
being the end products: pyruvate kinase (E.C. 2.7.1.40, Prokka_03100); pyruvate
formate-lyase (E.C. 2.3.1.54, Prokka_00010); formate hydrogenlyase E.C. 1.2.1.2,
Prokka_03349); phosphate acetyltransferase (E.C. 2.3.1.8, Prokka_00287); acetate
kinase (E.C. 2.7.2.1, Prokka_00288).
The fatty acid proﬁle comprises C16:0 (40.7%), C14:0 (15.7%), iso-C15:1/C13:0 3-OH
(12.2%), C19:0 10-methyl (7.6%), iso-C17:1 (5.2%) and C18:1 ω7c (5.2%). The diagnostic
amino acid of the peptidoglycan type ismeso-diaminopimelic acid. The type strain is
2-PG-424-CC-1T (=DSM 29489T = KCTC 15545T).
Description of Pasteurella caecimuris sp. nov. Pasteurella caecimuris (cae.ci.mu’ris.
L. n. caecum caecum; L. n. muris of a mouse; N. L. gen. n. caecimuris from the
caecum of a mouse). The nearest phylogenomic neighbour is Pasteurella
pneumotropica. dDDH between the genome of strain AA-424-CC-1T and
P. pneumotropica is 30.8%, conﬁrming the separate species status of strain
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AA-424-CC-1T. It is Gram-negative. It is positive for resoruﬁn-β-D-galactopyranoside,
β-galactosidase, α-galactosidase, alkaline phosphatase, trehalose, maltose, urease,
potassium nitrate, glucose and cytochrome oxidase (Rapid ID32 Strep and Api 20NE).
It has weak reactions for D-ribose, D-lactose, D-rafﬁnose, sodium pyruvate, melibiose
and sucrose.
N-acetyl D-glucosamine 6-phosphate can be converted to β-D-fructofuranose
6-phosphate (E.C. 3.5.1.25, deacetylase, Prokka_02486; E.C. 3.5.99.6, deaminase,
Prokka_02485). Glycogen debranching enzymes are present: E.C. 3.2.1.33,
α-glucosidase, Prokka_02499; E.C. 2.4.1.1, glycogen phosphorylase, Prokka_02298;
E.C. 5.4.2.8, mannomutase, Prokka_02405; E.C. 2.4.1.25, glucanotransferase,
Prokka_02299; E.C. 2.4.1.60, kinase, Prokka_02482. Sucrose can be converted to
β-D-fructofuranose, including the following reactions: E.C. 2.7.7.9, transferase,
Prokka_00902; E.C. 2.7.1.4, fructokinase, Prokka_01004; E.C. 5.4.2.8,
mannomutase, Prokka_02405; E.C. 5.3.1.9, isomerase, Prokka_01476. Xylose can be
converted to D-xylulose 5-phosphate, which may enter the pentose phosphate
pathway: E.C. 5.3.1.5, xylulose isomerase, Prokka_01918; E.C. 2.7.1.17, xylulose
kinase, Prokka_01919.
Enzymes for a mixed acid fermentation are detectable. Phosphoenolpyruvate can
be metabolized to form succinate, but also to form lactate from pyruvate. Pyruvate
can also be converted to formate and CO2 or to acetate via acetyl-CoA: E.C. 2.7.1.40,
kinase, Prokka_01479; E.C. 1.1.1.28, dehydrogenase, Prokka_00386; E.C. 2.3.1.54,
transferase, Prokka_02383; E.C. 2.3.1.8 phosphotransferase, Prokka_02157; E.C.
2.7.2.1, acetate kinase, Prokka_02158; E.C. 4.1.1.31, PEP-carboxylase,
Prokka_01077; E.C. 1.1.1.37, dehydrogenase, Prokka_01374; E.C. 4.2.1.2, fumarate
dehydrogenase, Prokka_02131; E.C. 1.3.5.4, fumarate reductase, Prokka_01183.
The fatty acid proﬁle comprises C16:0 (31.0%), C14:0 (29.4%), C16:1 ω7c/iso-C15:0 2-OH
(24.4%) and iso-C16:1/C14:0 3-OH (8.2%). The G+C content of genomic DNA is
40.2 mol%. The type strain is AA-424-CC-1T (=DSM 28627T = KCTC 52216T).
Description of Turicimonas gen. nov. Turicimonas (Tu.ri.ci mon’as. L. neut.
n Turicum the Roman name for the city of Zurich; Gr. fem. n. monas a unit, a
monad; N.L. fem. n. Turicimonas a unit of Turicum/Zurich; the type strain of the
type species was isolated in the Swiss city Zurich). The closest phylogenomic
neighbour is Parasutterella excrementihominis. The dDDH value and 16S rRNA
gene sequence identity between the two bacteria are 21.4 and 93.9%, respectively.
The amino acid identity (AAI) value between the two bacteria is 66.1% and the
difference in genomic G+C content is 4.1%. The G+C content of genomic DNA of
the type strain is 44.0 mol%. The type species is Turicimonas muris.
Description of Turicimonas muris sp. nov. Turicimonas muris (mu’.ris. L. gen.
n. muris of a mouse). It grows as single, straight, rod-shaped cells, 1–2 µm in length.
All reactions are negative in Api 20A and Rapid ID 32A. It is able to degrade
L-asparagine (E.C.5.1.1, Prokka_02303) and L-serine (E.C. 4.3.1.17, Prokka_01696).
The type strain is YL45T (= DSM 26109T = KCTC 15542T).
Accession codes. The genome and metagenome sequences obtained in the present
study are available at the European Nucleotide Archive under project accession no.
PRJEB10572 and at the Sequence Read Archives under accession nos. SRX1092347,
SRX109234, SRX1092352 to 55 and SRX1092357 to 62. These numbers and
the GenBank IDs of 16S rRNA genes of all miBC isolates are listed in
Supplementary Table 1.
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